FDA clears Corin hip replacement technology

Orthopedic robotics company Corin has earned FDA clearance for the ApolloHipX, a total replacement application designed for the Corin Apollo platform.

Advertisement

The ApolloHipX is the first and only hip replacement technology to integrate 3D preoperative planning with intraoperative fluoroscopy, which allows surgeons to implement personalized patient plans with greater precision and efficiency, according to a Jan. 14 news release. 

ApolloHipX uses 3D images to provide a more accurate assessment of a component position from a single image, according to the company. This will result in fewer intraoperative images and aims to optimize surgical efficiency while minimizing radiation exposure within the operating room. 

The application is also compatible with Corin’s full portfolio of hip implants, including the new Icona, a triple-taper, fully coated, cementless femoral stem. 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.